Human Albumin Grifols (human albumin) / Grifols - LARVOL DELTA

Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT) (clinicaltrials.gov) - P2 | N=52 | Completed | Sponsor: Fundacion Clinic per a la Recerca Biomédica | Not yet recruiting ➔ Completed | Trial completion date: Nov 2022 ➔ Jan 2025 | Trial primary completion date: Jul 2022 ➔ Dec 2024

Trial completion • Trial completion date • Trial primary completion date • Cardiovascular • Fibrosis • Heart Failure • Hepatology • Immunology • Liver Cirrhosis

Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT) (clinicaltrials.gov) - P2; N=52; Not yet recruiting; Sponsor: Fundacion Clinic per a la Recerca Biomédica; Trial completion date: Nov 2021 ➔ Nov 2022; Initiation date: Jul 2019 ➔ Jul 2020; Trial primary completion date: Jul 2021 ➔ Jul 2022

Clinical • Trial completion date • Trial initiation date • Trial primary completion date

Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT) (clinicaltrials.gov) - P2; N=52; Not yet recruiting; Sponsor: Fundacion Clinic per a la Recerca Biomédica

Clinical • New P2 trial